These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
248 related articles for article (PubMed ID: 23278282)
1. Concentration of tacrolimus and major metabolites in kidney transplant recipients as a function of diabetes mellitus and cytochrome P450 3A gene polymorphism. Chitnis SD; Ogasawara K; Schniedewind B; Gohh RY; Christians U; Akhlaghi F Xenobiotica; 2013 Jul; 43(7):641-9. PubMed ID: 23278282 [TBL] [Abstract][Full Text] [Related]
2. Association of CYP3A4-392A/G, CYP3A5-6986A/G, and ABCB1-3435C/T Polymorphisms with Tacrolimus Dose, Serum Concentration, and Biochemical Parameters in Mexican Patients with Kidney Transplant. Alatorre-Moreno EV; Saldaña-Cruz AM; Pérez-Guerrero EE; Morán-Moguel MC; Contreras-Haro B; López-de La Mora DA; Dávalos-Rodríguez IP; Marín-Medina A; Rivera-Cameras A; Balderas-Peña LA; Gómez-Ramos JJ; Cortés-Sanabria L; Salazar-Páramo M Genes (Basel); 2024 Apr; 15(4):. PubMed ID: 38674430 [TBL] [Abstract][Full Text] [Related]
3. Effect of CYP3A and ABCB1 single nucleotide polymorphisms on the pharmacokinetics and pharmacodynamics of calcineurin inhibitors: Part I. Staatz CE; Goodman LK; Tett SE Clin Pharmacokinet; 2010 Mar; 49(3):141-75. PubMed ID: 20170205 [TBL] [Abstract][Full Text] [Related]
4. Influence of combined CYP3A4 and CYP3A5 single-nucleotide polymorphisms on tacrolimus exposure in kidney transplant recipients: a study according to the post-transplant phase. Aouam K; Kolsi A; Kerkeni E; Ben Fredj N; Chaabane A; Monastiri K; Boughattas N Pharmacogenomics; 2015 Dec; 16(18):2045-54. PubMed ID: 26615671 [TBL] [Abstract][Full Text] [Related]
6. Effect of CYP3A and ABCB1 single nucleotide polymorphisms on the pharmacokinetics and pharmacodynamics of calcineurin inhibitors: Part II. Staatz CE; Goodman LK; Tett SE Clin Pharmacokinet; 2010 Apr; 49(4):207-21. PubMed ID: 20214406 [TBL] [Abstract][Full Text] [Related]
7. Tacrolimus concentrations in relation to CYP3A and ABCB1 polymorphisms among solid organ transplant recipients in Korea. Jun KR; Lee W; Jang MS; Chun S; Song GW; Park KT; Lee SG; Han DJ; Kang C; Cho DY; Kim JQ; Min WK Transplantation; 2009 Apr; 87(8):1225-31. PubMed ID: 19384171 [TBL] [Abstract][Full Text] [Related]
8. Influence of CYP3A5 and ABCB1 gene polymorphisms and other factors on tacrolimus dosing in Caucasian liver and kidney transplant patients. Provenzani A; Notarbartolo M; Labbozzetta M; Poma P; Vizzini G; Salis P; Caccamo C; Bertani T; Palazzo U; Polidori P; Gridelli B; D'Alessandro N Int J Mol Med; 2011 Dec; 28(6):1093-102. PubMed ID: 21922127 [TBL] [Abstract][Full Text] [Related]
9. CYP3A5*3 and ABCB1 61A>G Significantly Influence Dose-adjusted Trough Blood Tacrolimus Concentrations in the First Three Months Post-Kidney Transplantation. Hu R; Barratt DT; Coller JK; Sallustio BC; Somogyi AA Basic Clin Pharmacol Toxicol; 2018 Sep; 123(3):320-326. PubMed ID: 29603629 [TBL] [Abstract][Full Text] [Related]
10. Influence of CYP3A4, CYP3A5 and MDR-1 polymorphisms on tacrolimus pharmacokinetics and early renal dysfunction in liver transplant recipients. Shi Y; Li Y; Tang J; Zhang J; Zou Y; Cai B; Wang L Gene; 2013 Jan; 512(2):226-31. PubMed ID: 23107770 [TBL] [Abstract][Full Text] [Related]
11. The role of pharmacogenetics in the disposition of and response to tacrolimus in solid organ transplantation. Hesselink DA; Bouamar R; Elens L; van Schaik RH; van Gelder T Clin Pharmacokinet; 2014 Feb; 53(2):123-39. PubMed ID: 24249597 [TBL] [Abstract][Full Text] [Related]
12. The genetic polymorphisms of POR*28 and CYP3A5*3 significantly influence the pharmacokinetics of tacrolimus in Chinese renal transplant recipients. Zhang JJ; Liu SB; Xue L; Ding XL; Zhang H; Miao LY Int J Clin Pharmacol Ther; 2015 Sep; 53(9):728-36. PubMed ID: 26227094 [TBL] [Abstract][Full Text] [Related]
13. CYP3A and ABCB1 genetic polymorphisms on the pharmacokinetics and pharmacodynamics of tacrolimus and its metabolites (M-I and M-III). Yoon SH; Cho JH; Kwon O; Choi JY; Park SH; Kim YL; Yoon YR; Won DI; Kim CD Transplantation; 2013 Mar; 95(6):828-34. PubMed ID: 23364483 [TBL] [Abstract][Full Text] [Related]
14. CYP3A5 polymorphisms and their effects on tacrolimus exposure in an ethnically diverse South African renal transplant population. Muller WK; Dandara C; Manning K; Mhandire D; Ensor J; Barday Z; Freercks R S Afr Med J; 2020 Jan; 110(2):159-166. PubMed ID: 32657689 [TBL] [Abstract][Full Text] [Related]
15. CYP3A4/5 polymorphisms affect the blood level of cyclosporine and tacrolimus in Chinese renal transplant recipients. Li DY; Teng RC; Zhu HJ; Fang Y Int J Clin Pharmacol Ther; 2013 Jun; 51(6):466-74. PubMed ID: 23557867 [TBL] [Abstract][Full Text] [Related]
16. The combination of CYP3A4*22 and CYP3A5*3 single-nucleotide polymorphisms determines tacrolimus dose requirement after kidney transplantation. Lloberas N; Elens L; Llaudó I; Padullés A; van Gelder T; Hesselink DA; Colom H; Andreu F; Torras J; Bestard O; Cruzado JM; Gil-Vernet S; van Schaik R; Grinyó JM Pharmacogenet Genomics; 2017 Sep; 27(9):313-322. PubMed ID: 28704257 [TBL] [Abstract][Full Text] [Related]
17. CYP3A5 and CYP3A4, but not ABCB1 polymorphisms affect tacrolimus dose-adjusted trough concentrations in kidney transplant recipients. Kurzawski M; Dąbrowska J; Dziewanowski K; Domański L; Perużyńska M; Droździk M Pharmacogenomics; 2014 Feb; 15(2):179-88. PubMed ID: 24444408 [TBL] [Abstract][Full Text] [Related]
18. Influence of CYP3A4*22 and CYP3A5*3 combined genotypes on tacrolimus dose requirements in Egyptian renal transplant patients. Ebid AIM; Ismail DA; Lotfy NM; Mahmoud MA; ELSharkawy M J Clin Pharm Ther; 2022 Dec; 47(12):2255-2263. PubMed ID: 36379901 [TBL] [Abstract][Full Text] [Related]
19. A new functional CYP3A4 intron 6 polymorphism significantly affects tacrolimus pharmacokinetics in kidney transplant recipients. Elens L; Bouamar R; Hesselink DA; Haufroid V; van der Heiden IP; van Gelder T; van Schaik RH Clin Chem; 2011 Nov; 57(11):1574-83. PubMed ID: 21903774 [TBL] [Abstract][Full Text] [Related]
20. Long-Term Influence of CYP3A5, CYP3A4, ABCB1, and NR1I2 Polymorphisms on Tacrolimus Concentration in Chinese Renal Transplant Recipients. Liu F; Ou YM; Yu AR; Xiong L; Xin HW Genet Test Mol Biomarkers; 2017 Nov; 21(11):663-673. PubMed ID: 28945481 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]